2,850 results on '"Thyssen, Jacob P"'
Search Results
2. Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
3. Treat-to-Target in Atopic Dermatitis
4. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™): a clinical outcome measure for the severity of atopic dermatitis
5. A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment
6. Contact Dermatitis From Biomedical Devices, Implants, and Metals—Trouble From Within
7. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
8. Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin Cohort
9. Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: A cross sectional study
10. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa
11. No associations between type 1 diabetes and atopic dermatitis, allergic rhinitis, or asthma in childhood: a nationwide Danish case-cohort study
12. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation
13. A fragment of type VI collagen alpha-6 chain is elevated in serum from patients with atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and melanoma
14. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial
15. Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
16. Adverse events from topical corticosteroid use in chronic hand eczema — Findings from the Danish Skin Cohort
17. Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
18. Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study
19. The Proteome of Hand Eczema Assessed by Tape Stripping
20. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
21. Similar Skin Barrier Function in Persons with Type 1 Diabetes Compared with Healthy Controls
22. Reduced Skin Microbiome Diversity in Infancy Is Associated with Increased Risk of Atopic Dermatitis in High-Risk Children
23. Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis
24. Economic Burden of Chronic Hand Eczema: A Review
25. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
26. Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases
27. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries
28. Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review
29. Abrocitinib may improve itch and quality of life in patients with itch‐dominant atopic dermatitis.
30. Hypersensitivity Reactions to Orthopedic Implants
31. Contact Allergy to Metals
32. Hand Eczema: Causative Factors, Diagnosis, Personal and Societal Consequences
33. Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis
34. Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons
35. What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review
36. Erenumab for Treatment of Persistent Erythema and Flushing in Rosacea
37. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study
38. RNA‐sequencing of paired tape‐strips and skin biopsies in atopic dermatitis reveals key differences
39. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis
40. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
41. The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
42. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis
43. 548 - Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities
44. 552 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis
45. Hyperkeratotic Dermatitis of the Palms
46. Acute and Recurrent Vesicular Hand Dermatitis
47. Bidirectional association between atopic dermatitis, conjunctivitis, and other ocular surface diseases: A systematic review and meta-analysis
48. Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
49. Allergic Contact Dermatitis in Patients with Atopic Dermatitis
50. Rhinitis prevalence and association with atopic dermatitis: A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.